Global Economy

Ozempic Maker Sues Spas and Clinics Selling Custom-Made Versions



Novo Nordisk accused the firms of false advertising, trademark infringement and unfair competition.



READ SOURCE

Read More   China keeps benchmark lending rates steady as Fed signals fewer cuts ahead

This website uses cookies. By continuing to use this site, you accept our use of cookies.